Key result
Inferior vena cava filters remain important for patients with venous thromboembolism who cannot receive standard anticoagulation, despite limited data on effectiveness and survival benefit.
Why the study?
The use of inferior vena cava filters has been controversial, particularly following the introduction of retrievable filters and expanded or prophylactic indications.
IVC filters remain an important option for VTE patients with contraindications to anticoagulation, though their use requires careful management for retrieval and monitoring of adverse events.
Answers are grounded in this paper and cite their sources.
Supports selective IVC filter use when anticoagulation is contraindicated; leaves open need for RCTs on effectiveness and survival.
Introduction: Inferior vena cava (IVC) filters are mechanical filtration devices designed as an alternative to surgical ligation/plication of the IVC. Their use has been controversial, especially with the introduction of retrievable filters and expanded/prophylactic indications.Areas covered: Authors discuss the types of available IVC filters, indications for placement, evidence on their effectiveness in general and specific patient populations, procedural considerations, off-label use, complications, and filter retrieval. This review is based on manuscripts/abstracts published from 1960 to 2021 on venous thromboembolism and IVC filters.Expert opinion: Despite the limited data on their effectiveness and survival benefit, IVC filters continue to play an important role in the treatment of patients with venous thromboembolism (VTE) who cannot receive standard anticoagulation. There is no role of IVC filters in patients without VTE. While retrievable filters are desirable for short-term use, a dedicated team-based approach, and advanced training are required for their successful removal. Newer devices are promising in improving patient safety . The device manufacturers and regulatory agencies should consider specific approaches to track device-related adverse events. Population-based studies are required to establish optimal patient population who would benefit from these devices. .
No takes yet. Share an insight, caveat, or question.
Pillai et al. (2021) conducted a review in Venous thromboembolism. Inferior vena cava (IVC) filters was evaluated. Inferior vena cava filters remain important for patients with venous thromboembolism who cannot receive standard anticoagulation, despite limited data on effectiveness and survival benefit.
Synapse has enriched 10 related papers. Consider them for comparative context: